Literature DB >> 12354898

Use of spoligotyping for accurate classification of recurrent tuberculosis.

R M Warren1, E M Streicher, S Charalambous, G Churchyard, G D van der Spuy, A D Grant, P D van Helden, T C Victor.   

Abstract

The spoligotyping method has become an important tool for the tracking of Mycobacterium tuberculosis strains in different epidemiological settings. In this study, we demonstrate the ability of the spoligotyping technique to accurately determine the pathogenetic mechanism of recurrent disease. This methodology has advantages over conventional restriction fragment length polymorphism methods which may be useful in large-scale intervention studies.

Entities:  

Mesh：

Year:  2002        PMID： 12354898      PMCID： PMC130897          DOI： 10.1128/JCM.40.10.3851-3853.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  21 in total

1.  Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

Authors:  A van Rie; R Warren; M Richardson; T C Victor; R P Gie; D A Enarson; N Beyers; P D van Helden
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

2.  Insertion element IS987 from Mycobacterium bovis BCG is located in a hot-spot integration region for insertion elements in Mycobacterium tuberculosis complex strains.

Authors:  P W Hermans; D van Soolingen; E M Bik; P E de Haas; J W Dale; J D van Embden
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

3.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

Authors:  J D van Embden; M D Cave; J T Crawford; J W Dale; K D Eisenach; B Gicquel; P Hermans; C Martin; R McAdam; T M Shinnick
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

4.  Chromosomal DNA fingerprinting analysis using the insertion sequence IS6110 and the repetitive element DR as strain-specific markers for epidemiological study of tuberculosis in French Polynesia.

Authors:  G Torrea; G Levee; P Grimont; C Martin; S Chanteau; B Gicquel
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

5.  Epidemiologic usefulness of spoligotyping for secondary typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110.

Authors:  W A Cronin; J E Golub; L S Magder; N G Baruch; M J Lathan; L N Mukasa; N Hooper; J H Razeq; D Mulcahy; W H Benjamin; W R Bishai
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

6.  Genetic variation and evolutionary origin of the direct repeat locus of Mycobacterium tuberculosis complex bacteria.

Authors:  J D van Embden; T van Gorkom; K Kremer; R Jansen; B A van Der Zeijst; L M Schouls
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

7.  Nature of DNA polymorphism in the direct repeat cluster of Mycobacterium tuberculosis; application for strain differentiation by a novel typing method.

Authors:  P M Groenen; A E Bunschoten; D van Soolingen; J D van Embden
Journal:  Mol Microbiol       Date:  1993-12       Impact factor: 3.501

8.  Use of various genetic markers in differentiation of Mycobacterium bovis strains from animals and humans and for studying epidemiology of bovine tuberculosis.

Authors:  D van Soolingen; P E de Haas; J Haagsma; T Eger; P W Hermans; V Ritacco; A Alito; J D van Embden
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

9.  The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods.

Authors:  P M Small; P C Hopewell; S P Singh; A Paz; J Parsonnet; D C Ruston; G F Schecter; C L Daley; G K Schoolnik
Journal:  N Engl J Med       Date:  1994-06-16       Impact factor: 91.245

10.  Spoligotype database of Mycobacterium tuberculosis: biogeographic distribution of shared types and epidemiologic and phylogenetic perspectives.

Authors:  C Sola; I Filliol; M C Gutierrez; I Mokrousov; V Vincent; N Rastogi
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883
View more
  6 in total

1.  Mycobacterial interspersed repetitive unit typing of Mycobacterium tuberculosis compared to IS6110-based restriction fragment length polymorphism analysis for investigation of apparently clustered cases of tuberculosis.

Authors:  Peter M Hawkey; E Grace Smith; Jason T Evans; Philip Monk; Gerry Bryan; Huda H Mohamed; Madhu Bardhan; R Nicholas Pugh
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

2.  Automated high-throughput mycobacterial interspersed repetitive unit typing of Mycobacterium tuberculosis strains by a combination of PCR and nondenaturing high-performance liquid chromatography.

Authors:  Jason T Evans; Peter M Hawkey; E Grace Smith; Kerstin A Boese; Roderic E Warren; George Hong
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

Review 3.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

4.  High prevalence of drug resistance amongst HIV-exposed and -infected children in a tuberculosis prevention trial.

Authors:  A C Hesseling; S Kim; S Madhi; S Nachman; H S Schaaf; A Violari; T C Victor; G McSherry; C Mitchell; M F Cotton
Journal:  Int J Tuberc Lung Dis       Date:  2012-02       Impact factor: 2.373

5.  The study recurrent tuberculosis and exogenous reinfection, Shanghai, China.

Authors:  Guomiao Shen; Zhen Xue; Xin Shen; Bin Sun; Xiaohong Gui; Mei Shen; Jian Mei; Qian Gao
Journal:  Emerg Infect Dis       Date:  2006-11       Impact factor: 6.883

6.  The Effect of Combining Natural Terpenes and Antituberculous Agents against Reference and Clinical Mycobacterium tuberculosis Strains.

Authors:  Elwira Sieniawska; Rafal Sawicki; Marta Swatko-Ossor; Agnieszka Napiorkowska; Agata Przekora; Grazyna Ginalska; Ewa Augustynowicz-Kopec
Journal:  Molecules       Date:  2018-01-15       Impact factor: 4.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.